Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Dalton

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2019
Anatomical Correlates and Surgical Considerations for Localized Therapeutic Hypothermia Application in Cochlear Implantation SurgeryEnrique Perez, Andrea Viziano, Zaid Al-Zaghal, et al.
Nature Medicine|January 2, 2004
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsTianhong Wang, Guilian Niu, Marcin Kortylewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effectsLyudmila Burdelya, Maciej Kujawski, Guilian Niu, et al.
Blood|February 25, 2005
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cellsKuichun Zhu, Elvira Gerbino, Darrin M Beaupre, et al.
Communications Biology|May 15, 2021
G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilisAnnemarie Boleij, Payam Fathi, William Dalton, et al.
Antioxidants (Basel, Switzerland)|July 27, 2022
Profiling the Site of Protein CoAlation and Coenzyme A Stabilization InteractionsMaria-Armineh Tossounian, Maria Baczynska, William Dalton, et al.
Leukemia & Lymphoma|July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomideDana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Mayo Clinic Proceedings|July 13, 2004
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activityPaul Richardson, Robert Schlossman, Sundar Jagannath, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Cancer Research|April 13, 2017
An <i>Ex Vivo</i> Platform for the Prediction of Clinical Response in Multiple MyelomaAriosto Silva, Maria C Silva, Praneeth Sudalagunta, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2019
Anatomical Correlates and Surgical Considerations for Localized Therapeutic Hypothermia Application in Cochlear Implantation SurgeryEnrique Perez, Andrea Viziano, Zaid Al-Zaghal, et al.
Nature Medicine|January 2, 2004
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsTianhong Wang, Guilian Niu, Marcin Kortylewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effectsLyudmila Burdelya, Maciej Kujawski, Guilian Niu, et al.
Blood|February 25, 2005
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cellsKuichun Zhu, Elvira Gerbino, Darrin M Beaupre, et al.
Communications Biology|May 15, 2021
G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilisAnnemarie Boleij, Payam Fathi, William Dalton, et al.
Antioxidants (Basel, Switzerland)|July 27, 2022
Profiling the Site of Protein CoAlation and Coenzyme A Stabilization InteractionsMaria-Armineh Tossounian, Maria Baczynska, William Dalton, et al.
Leukemia & Lymphoma|July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomideDana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Mayo Clinic Proceedings|July 13, 2004
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activityPaul Richardson, Robert Schlossman, Sundar Jagannath, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Cancer Research|April 13, 2017
An <i>Ex Vivo</i> Platform for the Prediction of Clinical Response in Multiple MyelomaAriosto Silva, Maria C Silva, Praneeth Sudalagunta, et al.
Pageof 3